In cancer, CD8+ T cells can directly recognize and eliminate tumor cells through specific interactions between their T cell receptors and antigens presented on the tumor cells as short peptides (8–11 amino acids in length) in complex with HLA molecules. The gene discussed is CD8A; the disease is neoplasm.